Search results for "PROGRESS"

showing 10 items of 1620 documents

Purkinje cell loss and motor coordination defects in profilin1 mutant mice.

2012

Profilin1 is an actin monomer-binding protein, essential for cytoskeletal dynamics. Based on its broad expression in the brain and the localization at excitatory synapses (hippocampal CA3-CA1 synapse, cerebellar parallel fiber (PF)-Purkinje cell (PC) synapse), an important role for profilin1 in brain development and synapse physiology has been postulated. We recently showed normal physiology of hippocampal CA3-CA1 synapses in the absence of profilin1, but impaired glial cell binding and radial migration of cerebellar granule neurons (CGNs). Consequently, brain-specific inactivation of profilin1 by exploiting conditional mutants and Nestin-mediated cre expression resulted in a cerebellar hyp…

CerebellumPatch-Clamp TechniquesPurkinje cellBiophysicsAction PotentialsParallel fiberMice TransgenicNerve Tissue ProteinsBiologyHippocampal formationIn Vitro TechniquesMotor ActivitySynapseNestinMiceProfilinsPurkinje CellsIntermediate Filament ProteinsmedicineAnimalsGeneral NeuroscienceAge FactorsBrainGene Expression Regulation DevelopmentalLong-term potentiationElectric StimulationDisease Models Animalmedicine.anatomical_structurenervous systemCytoarchitectureAnimals NewbornCerebellar cortexMutationDisease ProgressionPsychomotor DisordersNeuroscienceNeuroscience
researchProduct

Are pelvic side-wall recurrences of cervical cancer biologically different from central relapses?

1994

Background. By using the Combined Operative and Radiotherapeutic Treatment (CORT) procedure, pelvic side-wall recurrences of gynecologic malignancies arising in a previously irradiated pelvis may be locally controlled. Local control of central relapses may be achieved by exenteration alone. If, in cervical cancer, both relapse patterns are biologically different (as hypothesized by some investigators), distinct disease courses after local treatment may be expected. Methods. Since June, 1989, 32 pelvic recurrences of cervical cancer were treated for local control in this institution. The median size of the recurrent tumors was 5 cm (range, 2–9 cm); 84% of the patients had been extensively ir…

Cervical cancerCancer Researchmedicine.medical_specialtyTumor sizebusiness.industryProportional hazards modelmedicine.medical_treatmentCancerDiseasemedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureOncologymedicinebusinessProgressive diseasePelvisCancer
researchProduct

Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall

1996

BACKGROUND. Whereas 25 to 50% of selected patients with gynecologic tumors who relapse centrally in an irradiated pelvis can be salvaged by exenteration, postirradiation recurrence infiltrating the pelvic side wall generally has been fatal. We have designed the combined operative and radiotherapeutic treatment (CORT) procedure for the treatment of postirradiation recurrence infiltrating the pelvic wall and developed several new techniques for its realization. The aim of the surgery is as follows : (1) total resection of the tumor with only a microscopic margin (R1) at the pelvic wall, preserving the bony pelvis and the neurovascular support of the leg ; (2) modulation of the therapeutic ind…

Cervical cancerCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentBrachytherapyThighNeurovascular bundlemedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureOncologyTumor progressionmedicineAbdomenbusinessPelvisCancer
researchProduct

Tumor Oxygenation and Tumor Vascularity: Evidence for Their Clinical Relevance in Cancer of the Uterine Cervix and Considerations on Their Potential …

1996

Most solid malignancies are thought to be derived from a single neoplastic precursor cell having lost proliferation control and gained the ability to penetrate basement membranes and to invade into the stroma. During the disease course tumors increase their overall cell number by local expansion and the development of regional and distant metastases. Along with the increase in cell number the tumors loose hormonal or other external signal dependencies and acquire resistances towards radio— and chemotherapy. The progressing disease causes symptoms through impaired tissue/organ functions and complications, and finally kills the individual (unless other causes leading to death become manifest …

Cervical cancerChemotherapyPathologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerDiseaseTumor Oxygenationmedicine.diseaseStromaTumor progressionPrecursor cellmedicinebusiness
researchProduct

Tuning the Magnetic Properties of Carbon by Nitrogen Doping of Its Graphene Domains

2015

Here we present the formation of predominantly sp-coordinate carbon with magnetic- and heteroatom-induced structural defects in a graphene lattice by a stoichiometric dehalogenation of perchlorinated (hetero)aromatic precursors [hexachlorobenzene, CCl (HCB), and pentachloropyridine, NCCl (PCP)] with transition metals such as copper in a combustion synthesis. This route allows the build-up of a carbon lattice by a chemistry free of hydrogen and oxygen compared to other pyrolytic approaches and yields either nitrogen-doped or -undoped graphene domains depending on the precursor. The resulting carbon was characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM…

ChemistryGrapheneScanning electron microscopeInorganic chemistryGeneral Chemistry7. Clean energyBiochemistryCatalysis3. Good healthlaw.inventionMagnetizationsymbols.namesakeColloid and Surface ChemistryX-ray photoelectron spectroscopylawTransmission electron microscopysymbolsCarbide-derived carbonPhysical chemistryPyrolytic carbonRaman spectroscopyCHEMICAL-VAPOR-DEPOSITION; N-DOPED GRAPHENE; RECENT PROGRESS; FILMS; ELECTROCATALYSTS; NANORIBBONS; RADICALS; STATE
researchProduct

Pathophysiology of Solid Tumors

2009

It is generally accepted that tumor blood flow, microcirculation, oxygen and nutrient supply, tissue pH distribution, lactate levels, and the bioenergetic status— factors that are usually closely linked and that define the so-called pathophysiological microenvironment (“tumor pathophysiome”)—can markedly influence the therapeutic response of malignant tumors to conventional irradiation, chemotherapy, other non-surgical treatment modalities, malignant progression, and the cell proliferation activity within tumors. Currently available information on the parameters defining the pathophysiological micromilieu in human tumors is presented in this chapter. According to these data, significant var…

ChemotherapyTumor hypoxiaCell growthbusiness.industrymedicine.medical_treatmentCancer researchmedicineMalignant progressionTumor responsebusinessGrading (tumors)PathophysiologyMicrocirculation
researchProduct

Eine neue experimentelle Methode zur Behandlung von Beckenwandrezidiven gynäkologischer Malignome

1989

Pelvic side wall recurrences of gynecological malignancies subsequent to primary or adjuvant radiation therapy have a bad prognosis, although in almost half of the cases, distant metastases are not present at the time of diagnosis of the local tumor progression. A radical operative resection of the pelvic wall recurrence is rarely possible and a second conventional percutaneous or intracavitary irradiation with a tumoricidal dose is no longer feasible, because of the limited radiation tolerance of the surrounding pelvic tissue. The different forms of chemotherapy applied at present are not curative. Based on considerations of tumor and radiation biology, we propose a new experimental treatm…

Chemotherapymedicine.medical_specialtyRadiobiologyPercutaneousbusiness.industrymedicine.medical_treatmentBrachytherapyObstetrics and GynecologyTumor progressionRadioresistanceMaternity and MidwiferymedicineRadiologySurgical FlapsbusinessFixation (histology)Geburtshilfe und Frauenheilkunde
researchProduct

Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour

2014

Abstract Background To explore the activity of pazopanib in solitary fibrous tumour (SFT). Patients and methods In a preclinical study, we compared the activity of pazopanib, sorafenib, sunitinib, regorafenib, axitinib and bevacizumab in a dedifferentiated-SFT (DSFT) xenotransplanted into Severe Combined Immunodeficiency (SCID) mice. Antiangiogenics were administered at their reported optimal doses when mean tumour volume (TV) was 80 mm3. Drug activity was assessed as TV inhibition percentage (TVI%). From May 2012, six consecutive patients with advanced SFT received pazopanib, on a national name-based programme. In one case sunitinib was administered after pazopanib failure. Results In the …

Chemotherapy; Pazopanib; Sarcoma; Solitary fibrous tumour; Sunitinib; Tyrosine kinase; Administration Oral; Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies Monoclonal Humanized; Antineoplastic Agents; Bevacizumab; Humans; Imidazoles; Indazoles; Indoles; MAP Kinase Signaling System; Male; Mice SCID; Middle Aged; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Receptor Platelet-Derived Growth Factor beta; Solitary Fibrous Tumors; Sulfonamides; Transplantation Heterologous; Vascular Endothelial Growth Factor Receptor-2; Cancer Research; Oncology; Medicine (all)OncologyMaleCancer ResearchIndolesAxitinibPyridinesPyridinemedicine.medical_treatmentSolitary fibrous tumourAdministration OralAngiogenesis InhibitorsMice SCIDPharmacologyPyrroleAntineoplastic Agentchemistry.chemical_compoundMiceSolitary Fibrous TumorChemotherapy; Pazopanib; Sarcoma; Solitary fibrous tumour; Sunitinib; Tyrosine kinase; Cancer Research; Oncology; Medicine (all)Transplantation HeterologouMonoclonalSunitinibHumanizedSulfonamidesHeterologousSunitinibMedicine (all)ImidazolesSarcomaMiddle AgedSorafenibPlatelet-Derived Growth Factor betaAxitinibBevacizumabOncologySolitary Fibrous TumorsAdministrationAngiogenesis InhibitorHumanmedicine.drugReceptorPhenylurea CompoundSorafenibOralAdultNiacinamidemedicine.medical_specialtyIndazolesBevacizumabMAP Kinase Signaling SystemTransplantation HeterologousAntineoplastic AgentsSulfonamideAntibodies Monoclonal HumanizedSCIDAntibodiesReceptor Platelet-Derived Growth Factor betaPazopanibInternal medicineRegorafenibmedicineAnimalsHumansChemotherapyPyrrolesImidazoleTyrosine kinaseAgedChemotherapyTransplantationAnimalbusiness.industryPhenylurea CompoundsPazopanibmedicine.diseaseChemotherapy; Pazopanib; Sarcoma; Solitary fibrous tumour; Sunitinib; Tyrosine kinase; Administration Oral; Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies Monoclonal Humanized; Antineoplastic Agents; Axitinib; Bevacizumab; Humans; Imidazoles; Indazoles; Indoles; MAP Kinase Signaling System; Male; Mice SCID; Middle Aged; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Receptor Platelet-Derived Growth Factor beta; Solitary Fibrous Tumors; Sorafenib; Sulfonamides; Sunitinib; Transplantation Heterologous; Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-2IndazolePyrimidinesPyrimidinechemistryIndolebusinessProgressive diseaseNeoplasm Transplantation
researchProduct

Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.

2019

BACKGROUND Long-term exposure to hypertonic and high glucose in peritoneal dialysis fluid can result in peritoneal fibrosis. Spleen tyrosine kinase (SYK) has a role in inflammation and fibrosis. This study aimed to investigate the role of SYK in an in vivo rat model of peritoneal fibrosis and in rat peritoneal mesothelial cells (PMCs) in vitro and to investigate the underlying mechanisms. MATERIAL AND METHODS Sprague-Dawley rats (N=24) were randomized into the sham control group (N=6); the peritoneal fibrosis group (N=6) treated with intraperitoneal chlorhexidine digluconate; the SYK inhibitor group (N=6), treated with chlorhexidine digluconate and fostamatinib; and the TGF-s inhibitor grou…

ChinaSykInflammation030204 cardiovascular system & hematologyPharmacologyFostamatinibRats Sprague-DawleyTransforming Growth Factor beta103 medical and health sciences0302 clinical medicineWestern blotIn vivoFibrosismedicineAnimalsSyk KinaseSmad3 ProteinPeritoneal Fibrosismedicine.diagnostic_testChemistryAnimal StudyChlorhexidinePeritoneal FibrosisGeneral Medicinemedicine.diseaseRatsDisease Models AnimalNephrology030220 oncology & carcinogenesisDisease Progressionmedicine.symptomPeritoneumPeritoneal DialysisTransforming growth factormedicine.drugSignal TransductionMedical science monitor : international medical journal of experimental and clinical research
researchProduct

A lymphocyte-glia connection sets the pace for smoldering inflammation

2021

Successful therapeutic options directly targeting disability progression in patients with multiple sclerosis (MS), a chronic inflammatory disorder of the central nervous system, are lacking. Now, a study published in Nature by Absinta and colleagues profiles a lymphocyte-glia connection at the edge of chronic active lesions that continuously drives neurodegenerative pathways.

Chronic ActiveLymphocyteMultiple sclerosisCentral nervous systemInflammationBiologymedicine.diseaseChronic inflammatory disorderGeneral Biochemistry Genetics and Molecular Biologymedicine.anatomical_structuremedicineIn patientDisability progressionmedicine.symptomNeuroscienceCell
researchProduct